GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

UPDATE 3-UK AstraZeneca vaccine plant partially evacuated over suspect package

Wed, 27th Jan 2021 13:15

(Updates with police confirmation of bomb squad presence)

LONDON, Jan 27 (Reuters) - A factory in Wales that produces
AstraZeneca's COVID-19 vaccine was partially evacuated
on Wednesday after it received a suspicious package and police
said a bomb disposal unit was dealing with the incident.

Operated by Wockhardt UK, the plant provides so-called
fill-and-finish capacity for AstraZeneca's UK supply chain,
which is the final manufacturing step of putting vaccines into
vials or syringes and packaging them.

AstraZeneca has agreed to supply Britain with 100 million
doses of the vaccine, developed by Oxford University.

It is currently engaged in a dispute with the European Union
after it cut supplies to the bloc due to production issues at
its Belgian factory.

"Wockhardt UK in Wrexham this morning received a suspicious
package to site. All relevant authorities were immediately
notified and engaged," the company said, referring to its
facility outside the town of Wrexham in north Wales.

"Upon expert advice we have partially evacuated the site
pending a full investigation. The safety of our employees and
business continuity remain of paramount importance," it said.

Local police confirmed that a bomb disposal unit was on site
and advised the public to avoid the area.

"We are currently dealing with an ongoing incident on the
Wrexham Industrial Estate," they said in a statement.
(Reporting by Alistair Smout, Michael Holden and Guy
Faulconbridge; Editing by Estelle Shirbon and David Clarke)

Related Shares

More News
Today 09:52

LONDON BROKER RATINGS: Berenberg raises Taylor Wimpey to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday:

Today 09:27

AstraZeneca completes USD2.4 billion Fusion Pharmaceuticals purchase

(Alliance News) - AstraZeneca PLC on Wednesday said it successfully completed the acquisition of Boston, Massachusetts-based Fusion Pharmaceuticals In...

3 Jun 2024 08:59

AstraZeneca cancer treatment Tagrisso recommended for approval in EU

(Alliance News) - AstraZeneca PLC said that, following further positive findings in clinical trial, Tagrisso has been recommended for use in the Europ...

3 Jun 2024 07:28

AstraZeneca's lung cancer treatment recommended for approval in EU

(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommend...

2 Jun 2024 20:03

Astra's Enhertu breast cancer trial shows 'unprecedented' results

June 2 (Reuters) - AstraZeneca and Daiichi Sankyo's Enhertu slows the progression of breast cancer by about five months in women whose disease worse...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.